Literature DB >> 11359341

Three-dimensional contrastless varicography by spiral computed tomography.

A Caggiati1, S Ricci, A Laghi, G Luccichenti, P Pavone.   

Abstract

OBJECTIVE: to report and discuss preliminary results obtained in varicose limbs by means of a volume rendering (VR)-computed tomography (CT) technique without contrast medium injection.
MATERIALS AND METHODS: VR-CT and duplex sonography (US) were performed to visualise the superficial veins of the lower extremity in eight healthy and 12 varicose limbs.
RESULTS: VR-CT clearly demonstrated the 3D arrangement of the superficial veins and visualised small sized veins which were not visible at US examination.
CONCLUSIONS: VR-CT is not suitable for routine evaluation of varicose limbs. VR-CT 3D reconstructions may be useful in the evaluation of atypical varicosis. Further studies are needed to define the role of VR-CT in deep venous disease. Copyright 2001 Harcourt Publishers Limited.

Entities:  

Mesh:

Year:  2001        PMID: 11359341     DOI: 10.1053/ejvs.2000.1263

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  4 in total

1.  Preoperative evaluation of the saphenous vein by 3-D contrastless computed tomography.

Authors:  Yuji Maruyama; Hajime Imura; Makoto Shirakawa; Masami Ochi
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-01-17

2.  Could Non-contrast 3DCT-Venography Be the First-Choice Diagnostic Imaging Modality for the Treatment of Varicose Vein?

Authors:  Yoshifumi Takahashi; Masaki Kokubo; Tetsuya Nozaka
Journal:  Ann Vasc Dis       Date:  2016-01-25

3.  Three-dimensional CT Venography: A Diagnostic Modality for the Preoperative Assessment of Patients with Varicose Veins.

Authors:  Katsutoshi Sato; Kazumasa Orihashi; Shinya Takahashi; Taiichi Takasaki; Tatsuya Kurosaki; Katsuhiko Imai; Minoru Ishifuro; Taijiro Sueda
Journal:  Ann Vasc Dis       Date:  2011-07-29

Review 4.  Female Pelvic Vein Embolization: Indications, Techniques, and Outcomes.

Authors:  Anthony James Lopez
Journal:  Cardiovasc Intervent Radiol       Date:  2015-03-25       Impact factor: 2.740

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.